Development and characterization of a quantitative ELISA to detect anti-SARS-CoV-2 spike antibodies

Development and characterization of a quantitative ELISA to detect anti-SARS-CoV-2 spike antibodies

A novel clinical assay for the detection and quantitation of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was adapted from an in-house, research-based enzyme-linked immunosorbent assay (ELISA). Development and validation were performed under regulatory guidelines,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Magdalena M. Żak, Aryeh Stock, Daniel Stadlbauer, Wei Zhang, Kirstie Cummings, William Marsiglia, Arsen Zargarov, Fatima Amanat, Monica Tamayo, Carlos Cordon-Cardo, Florian Krammer, Damodara Rao Mendu
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Coronavirus disease 2019
Severe acute respiratory syndrome coronavirus-2 (SARSCoV-2)
Antibody tests
Diagnosis of COVID-19
ELISA
IgG antibody assay
Science (General)
Q1-390
Social sciences (General)
H1-99
Acceso en línea:https://doaj.org/article/5c72781bae044eaf93031c713d193335
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/5c72781bae044eaf93031c713d193335

Ejemplares similares